TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Executive Medicine AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,545
|
3,326
|
3,214 |
| Financial expenses |
7
|
7
|
10 |
| Earnings before taxes |
-124
|
34
|
303 |
| EBITDA |
-117
|
41
|
313 |
| Total assets |
345
|
475
|
396 |
| Current assets |
329
|
458
|
380 |
| Current liabilities |
311
|
386
|
310 |
| Equity capital |
34
|
89
|
86 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
6
|
7
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
9.9%
|
18.7%
|
21.7% |
| Turnover per employee |
424
|
475
|
643 |
| Profit as a percentage of turnover |
-4.9%
|
1.0%
|
9.4% |
| Return on assets (ROA) |
-33.9%
|
8.6%
|
79.0% |
| Current ratio |
105.8%
|
118.7%
|
122.6% |
| Return on equity (ROE) |
-364.7%
|
38.2%
|
352.3% |
| Change turnover |
-671
|
95
|
1,189 |
| Change turnover % |
-21%
|
3%
|
59% |
| Chg. No. of employees |
-1
|
2
|
2 |
| Chg. No. of employees % |
-14%
|
40%
|
67% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.